Skip to content

Clinical trials

Phase 3 Graft vs Host Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 3 Country / region: Italy Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20161
20175
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
Adienne SA1
Equillium1
European Society for Blood and Marrow Transplantation1
Kiadis Pharma1
Mesoblast, Inc.1
Novartis Pharmaceuticals1
Pharmacyclics LLC.1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease10
Bronchiolitis Obliterans Syndrome2
Hematologic Neoplasms1
Immune System Diseases1
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Renal Insufficiency1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.